Skip to main content
. 2023 Mar 24;7(4):e0105. doi: 10.1097/HC9.0000000000000105

TABLE 3.

Summary of liver organoids modeling secondary liver cancers

Original tumor sources Species source Cell sources Culture system Applications Limitations References
CRC Human CRLM samples Matrigel Patient-specific anticancer drug screening Incomplete recapitulation of CRLM phenotypes 97
CRC and GOC Human Liver metastases from CRC and GOC Matrigel Anticancer drug sensitivity testing Restrained experimental scale 98
CRC Human CRLM samples Matrigel Drug screening;
Individualized treatment
Lack of coclinical trails 99
Rectal cancer Human Surgically resected initial and recurrent liver metastases from rectal cancer Matrigel Spatio-temporal pharmacogenomic analysis;
Drug screening
Inconsistent drug response of PDOs and liver metastases 100

Abbreviations: CRC, colorectal carcinoma; CRLM, CRC liver metastases; GOC, gastroesophageal carcinoma; PDO, patient-derived organoid.